Caspase-3 in serum predicts outcome after aneurysmal subarachnoid hemorrhage

Jie Wang1, Jian-Feng Wang1, Xiao-Ming Hu1

  • 1Department of Neurosurgery, Taizhou Hospital of Zhejiang Province, 150 Ximen Street, Linhai 317000, PR China.

Insights

Elevated serum caspase-3 activities correlate with aneurysmal subarachnoid hemorrhage (aSAH) severity and poor prognosis. These caspase-3 levels can predict outcomes, offering a potential biomarker for aSAH patients.

Area of Science:

  • Biomarkers in Neurology
  • Apoptosis Research
  • Neurocritical Care

Background:

  • Caspase-3 is a key enzyme in apoptosis, making it a potential indicator of cellular damage.
  • Aneurysmal subarachnoid hemorrhage (aSAH) is a critical neurological condition with significant morbidity and mortality.
  • Understanding markers of disease severity and prognosis in aSAH is crucial for patient management.

Purpose of the Study:

  • To investigate the temporal changes in serum caspase-3 activity following aSAH.
  • To analyze the relationship between serum caspase-3 activity and the severity of aSAH.
  • To evaluate the predictive value of serum caspase-3 activity for patient outcomes after aSAH.

Main Methods:

  • Serum caspase-3 activities were measured in 118 controls and 118 aSAH patients at various time points (admission, days 1, 2, 3, 5, 7).
  • Comparisons were made based on time to blood sampling, World Federation of Neurological Surgeons (WFNS) scores, and modified Fisher scores.
  • Six-month outcomes were assessed using the Glasgow Outcome Scale (GOS).

Main Results:

  • Serum caspase-3 activities were significantly elevated in aSAH patients compared to controls, peaking on day 3 post-hemorrhage.
  • Higher caspase-3 levels were observed in patients with unfavorable outcomes (GOS 1-3), correlating with WFNS and modified Fisher scores.
  • Admission and day 3 caspase-3 activities independently predicted poor outcomes, even after adjusting for age and severity scores.

Conclusions:

  • Increased serum caspase-3 activity is strongly associated with aSAH severity.
  • Serum caspase-3 activity serves as a valuable prognostic marker for aSAH.
  • Caspase-3 warrants further investigation as a potential therapeutic target or diagnostic tool in aSAH.
Abstract

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
438
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
14.5K
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
486
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
384